The GW Cancer Center is proud of its physician scientists and their commitment to medical research. These clinical studies are designed to add to the medical knowledge base and relate to the treatment, diagnosis, and prevention of diseases or conditions. The studies listed below are currently open to new patients. To learn more or enroll in a study, please call the phone number listed under "Contact Info" for the study of interest.
Clinical Program | Title | Description |
---|---|---|
Urological Oncology Program | Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer) |
Primary objective: Secondary objectives:
Inclusion Criteria:
|
Urological Oncology Program | Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study |
Primary objective: Secondary objectives:
|